Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
97 hedge funds and large institutions have $92.1M invested in Avid Bioservices, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 27 reducing their positions, and 14 closing their positions.
0% more capital invested
Capital invested by funds: $91.9M → $92.1M (+$230K)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 27
4% less funds holding
Funds holding: 101 → 97 (-4)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
AltraVue Capital
Bellevue,
Washington
|
+$2.67M |
| 2 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$1.07M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$918K |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$771K |
| 5 |
LCM
Legato Capital Management
San Francisco,
California
|
+$645K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.17M |
| 2 |
BP
Bandera Partners
New York
|
-$1.63M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$1.45M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.4M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.05M |
CDMO Hedge Fund Activity: Q1 2019 in Review
97 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q1 2019, worth a combined $92.1M — up 0.25% from $91.9M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CDMO and 11 opened new positions — a net loss of 3 holders — while 27 trimmed existing stakes and 27 added.
The largest buyer was AltraVue Capital, adding an estimated $2.67M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $3.17M sold.
- 97 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q1 2019, down from 101 in Q4 2018.
- Funds reported $92.1M of Avid Bioservices, Inc. Common Stock stock for Q1 2019, up 0.25% quarter-over-quarter.
- 11 funds opened new Avid Bioservices, Inc. Common Stock positions in Q1 2019 and 14 closed out, a net change of -3 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q1 2019 was AltraVue Capital, an estimated $2.67M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q1 2019 was Driehaus Capital Management, an estimated $3.17M sold.
Based on aggregated 13F filings for Q1 2019.